| P2093 | author name string | Vinay Tergaonkar | |
| | Ekta Khattar | |
| P2860 | cites work | Identification and characterization of the ubiquitously occurring nuclear matrix protein NMP 238 | Q22007994 |
| | X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions | Q24317067 |
| | A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis | Q24323178 |
| | Human telomerase and its regulation | Q24533247 |
| | Opposite orientations of DNA bending by c-Myc and Max | Q24564314 |
| | Telomere elongation in immortal human cells without detectable telomerase activity | Q24598626 |
| | IDH1 and IDH2 mutations in gliomas | Q24648948 |
| | There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer | Q24794266 |
| | hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer | Q24815255 |
| | Reactivation of telomerase in cancer | Q26769014 |
| | X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors | Q27640369 |
| | Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 |
| | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| | Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family | Q28256480 |
| | The RNA component of human telomerase | Q28288330 |
| | Protein composition of catalytically active human telomerase from immortal cells | Q28295708 |
| | Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells | Q28308249 |
| | Signaling to NF-kappaB | Q29547844 |
| | Highly recurrent TERT promoter mutations in human melanoma | Q29614798 |
| | A survey of telomerase activity in human cancer | Q29614858 |
| | TERT promoter mutations in familial and sporadic melanoma | Q29614920 |
| | Telomerase catalytic subunit homologs from fission yeast and human | Q29615387 |
| | MYC on the path to cancer | Q29619979 |
| | PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells | Q33515919 |
| | Human TIP49b/RUVBL2 gene: genomic structure, expression pattern, physical link to the human CGB/LHB gene cluster on chromosome 19q13.3. | Q33918666 |
| | Regulation of the human catalytic subunit of telomerase (hTERT). | Q34180715 |
| | Role of Ets/Id proteins for telomerase regulation in human cancer cells | Q34275975 |
| | hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions | Q34329231 |
| | Telomerase regulation: not just flipping the switch | Q34493169 |
| | Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection | Q34509804 |
| | Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf. | Q34551813 |
| | Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. | Q35041364 |
| | mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. | Q47823442 |
| | Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene | Q47986055 |
| | c-MYC and h-TERT co-expression in colon adenocarcinoma: a tissue microarray digitized image analysis | Q48518577 |
| | Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation. | Q51481805 |
| | Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene | Q51647786 |
| | Estrogen activates telomerase. | Q53415747 |
| | Elevated telomerase activity,c-MYC-, andhTERTmRNA expression: association with tumour progression in malignant lipomatous tumours | Q60689210 |
| | Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines | Q73851376 |
| | The correlation of TERT expression with c-myc expression in cervical cancer | Q73917896 |
| | Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells | Q78109137 |
| | A major role of PKC theta and NFkappaB in the regulation of hTERT in human T lymphocytes | Q79399651 |
| | MYC amplification and TERT expression in breast tumor progression | Q80682652 |
| | Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter | Q80809997 |
| | Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc. | Q35676663 |
| | Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity | Q35720003 |
| | E2F1: a potential negative regulator of hTERT transcription in normal cells upon activation of oncogenic c-Myc | Q36577182 |
| | Transduction of E2F-1 TAT fusion proteins represses expression of hTERT in primary ductal breast carcinoma cell lines | Q36593473 |
| | Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation. | Q36635311 |
| | Telomerase reactivation in cancers: Mechanisms that govern transcriptional activation of the wild-type vs. mutant TERT promoters | Q36857933 |
| | Differential repression of human and mouse TERT genes during cell differentiation | Q37181538 |
| | Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression | Q37395716 |
| | Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas | Q37514988 |
| | Ets2 transcription factor, telomerase activity and breast cancer | Q37536336 |
| | Telomerase: an RNP enzyme synthesizes DNA. | Q37775786 |
| | Non-canonical NF-κB signaling pathway | Q37822660 |
| | Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. | Q38288761 |
| | htert expression correlates with MYC over-expression in human prostate cancer | Q38304869 |
| | Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation | Q38304986 |
| | Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). | Q38316509 |
| | The hTERT gene is embedded in a nuclease-resistant chromatin domain | Q38334852 |
| | hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. | Q38357350 |
| | Noncanonical NF-κB Signaling in Health and Disease | Q38779134 |
| | Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. | Q38874534 |
| | Epidermal growth factor activates telomerase activity by direct binding of Ets-2 to hTERT promoter in lung cancer cells | Q38909930 |
| | Dual roles of c-Myc in the regulation of hTERT gene | Q38961879 |
| | E2F-1 represses transcription of the human telomerase reverse transcriptase gene | Q39095418 |
| | Pyk2/ERK 1/2 mediate Sp1- and c-Myc-dependent induction of telomerase activity by epidermal growth factor | Q39998587 |
| | Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors | Q40078363 |
| | Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms | Q40371754 |
| | Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells | Q40540408 |
| | Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours | Q40628061 |
| | Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor | Q40635037 |
| | Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression | Q40739034 |
| | Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). | Q40953506 |
| | Direct activation of TERT transcription by c-MYC. | Q40973563 |
| | Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues | Q41235699 |
| | Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair | Q41719677 |
| | Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase | Q42436923 |
| | Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells | Q42537507 |
| | NFκB drives TERT promoter reactivation in cancer | Q42910096 |
| | Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process | Q43238586 |
| | hTERT mRNA expression correlates with telomerase activity in human breast cancer | Q44414127 |
| | Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. | Q45953731 |
| | Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells | Q46417186 |
| | Telomerase and c-myc expression in hepatocellular carcinomas | Q47820938 |
| P304 | page(s) | 1 | |
| P577 | publication date | 2017-01-26 | |
| P1433 | published in | Frontiers in Cell and Developmental Biology | Q27725488 |
| P1476 | title | Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC. | |
| P478 | volume | 5 | |